Garrix Pharma Private Limited
About Garrix Pharma Private Limited
Data last updated:
Garrix Pharma Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 28 July 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24290DL2020PTC366987. Its GSTIN is 22AAICG4220F1Z6 (Chhattisgarh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Gudia Mishra and Sudhakar Mishra.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H.No. A – 12 Kh. No – 42/11/2 Dass Garden Baprola, New Delhi, Delhi, India – 110043.
As per the financials filed for FY 2024, the company reported a revenue of ₹24.35 Lakh, a growth of 59% compared to the previous year. For the same year it recorded a net profit of ₹1.21 Lakh (net margin 5%) and EBITDA of ₹1.66 Lakh (EBITDA margin 6.8%). Revenue has grown at a compounded annual rate (CAGR) of 102% over three years.
As per MCA filings, the company has open charges of ₹12 Lakh on record.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressH.No. A – 12 Kh. No – 42/11/2 Dass Garden Baprola, New Delhi, Delhi, India – 110043
- IndustryChemicals, Manufacturing, Other Chemical Product
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Garrix Pharma Private Limited
The main business activity of Garrix Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Garrix Pharma Private Limited FY 2025 filings available
Garrix Pharma Private Limited reported revenue of ₹24.35 Lakh (up 59% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Garrix Pharma Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 102% over three years, including 59% growth in the latest year. EBITDA rose 36% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Garrix Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• |
| EBITDA | ₹1.66 Lakh | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1.21 Lakh | •••• | •••• | •••• |
| Balance Sheet | ||||
| Share Capital | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• |
Financial Ratios of Garrix Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 6.8% | •••• | •••• | •••• |
| Net Profit Margin | 5% | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• |
| Liquidity and Debt | ||||
| Current Ratio | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• |
| Efficiency and Growth | ||||
| Asset Turnover | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Garrix Pharma are in the company report.
Financial statements from FY 2021
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Garrix Pharma Private Limited
Garrix Pharma Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Cure Mantra Herbs Private Limited | ₹24.42 Lakh (FY 2025) | •••• | •••• | -7.0% | •••• | New Delhi, Delhi, India |
| Hipace Pharmaceutical Private Limited | ₹24.41 Lakh (FY 2024) | •••• | •••• | 99.0% | •••• | Delhi, India |
| Amtrack Laboratories Pvt Ltd | ₹24.4 Lakh (FY 2025) | •••• | •••• | 12.0% | •••• | Mumbai, Maharashtra, India |
| Clonz Biotech Private Limited | ₹24.39 Lakh (FY 2025) | •••• | •••• | -67.0% | •••• | Hyderabad, Telangana, India |
| Parosha Chemicals Private Limited | ₹24.38 Lakh (FY 2023) | •••• | •••• | 326.0% | •••• | Vadodara, Gujarat, India |
| Garrix Pharma Private Limited this company | ₹24.35 Lakh (FY 2024) | •••• | •••• | 59.0% | •••• | New Delhi, Delhi, India |
| Nikit Chem Retails Private Limited | ₹24.32 Lakh (FY 2024) | •••• | •••• | 131.0% | •••• | Ludhiana, Punjab, India |
| Thoshe Air Purifications Private Limited | ₹24.25 Lakh (FY 2024) | •••• | •••• | 40.0% | •••• | Pen, Maharashtra, India |
| Virgin Minerals Private Limited | ₹24.25 Lakh (FY 2025) | •••• | •••• | -41.0% | •••• | Jaipur, Rajasthan, India |
| Satv Lifesciences Private Limited | ₹24.22 Lakh (FY 2023) | •••• | •••• | 159.0% | •••• | Pune, Maharashtra, India |
| Ortis Pharma Private Limited | ₹24.22 Lakh (FY 2025) | •••• | •••• | 13.0% | •••• | Ghaziabad, Uttar Pradesh, India |
Peers are the five companies nearest above and the five nearest below Garrix Pharma by revenue in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Garrix Pharma Private Limited
Garrix Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Gudia Mishra | Director | 28 Jul 2020 | 6 Years 2 Months | Current |
| Sudhakar Mishra | Director | 28 Jul 2020 | 6 Years 2 Months | Current |
Ownership and Shareholding of Garrix Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Garrix Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Feb 2023 | Others | ₹12 Lakh | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Garrix Pharma Private Limited
Garrix Pharma Private Limited has a workforce of 0 employees as of Apr 04, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Garrix Pharma Private Limited
Garrix Pharma Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Gudia Mishra was appointed as Director on 28 Jul 2020.
Credit Ratings, Litigation & Regulatory Alerts for Garrix Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Garrix Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Garrix Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Garrix Pharma Private Limited
Garrix Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 22AAICG4220F1Z6 | Chhattisgarh | Active | 09 Aug 2020 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Garrix Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Garrix Pharma Private Limited
Garrix Pharma is an active private limited company based in New Delhi, Delhi, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 28 July 2020 (6+ years old) and is registered under CIN U24290DL2020PTC366987.
Garrix Pharma reported revenue of ₹24.35 Lakh for FY 2024 (up 59% YoY).
Garrix Pharma has 2 current directors:
- Gudia Mishra - Director
- Sudhakar Mishra - Director
Garrix Pharma reported a net profit of ₹1.21 Lakh (net margin 5%) and EBITDA of ₹1.66 Lakh (EBITDA margin 6.8%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Garrix Pharma is 102% over three years. In the latest year (FY 2024) revenue rose 59%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Garrix Pharma is 22AAICG4220F1Z6, registered in Chhattisgarh.
The CIN (Corporate Identification Number) of Garrix Pharma is U24290DL2020PTC366987. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Garrix Pharma was incorporated on 28 July 2020, making it 6+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Garrix Pharma by revenue are Cure Mantra Herbs Private Limited, Hipace Pharmaceutical Private Limited, Amtrack Laboratories Pvt Ltd, Clonz Biotech Private Limited, Parosha Chemicals Private Limited and 5 more, all in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Gudia Mishra was appointed as Director on 28 Jul 2020. Sudhakar Mishra was appointed as Director on 28 Jul 2020.
The registered office of Garrix Pharma is at H.No. A – 12 Kh. No – 42112 Dass Garden Baprola, New Delhi, Delhi, India – 110043.